p19^ARF and Ras^V12 Offer Opposing Regulation of DHX33 Translation To Dictate Tumor Cell Fate

REFERENCES

• Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell 144:646–674.
   PubMedGoogle Scholar
• Luo J, Solimini NL, Elledge SJ. 2009. Principles of cancer therapy: oncogene and non-oncogene addiction. Cell 136:823–837.
   PubMed Web of Science ®Google Scholar
• Drygin D, Rice WG, Grummt I. The RNA polymerase I transcription machinery: an emerging target for the treatment of cancer. Annu. Rev. Pharmacol. Toxicol. 50:131–156.
   PubMedGoogle Scholar
• Maggi LBJr, Weber JD. 2005. Nucleolar adaptation in human cancer. Cancer Invest. 23:599–608.
   PubMed Web of Science ®Google Scholar
• Montanaro L, Trere D, Derenzini M. 2008. Nucleolus, ribosomes, and cancer. Am. J. Pathol. 173:301–310.
   PubMed Web of Science ®Google Scholar
• White RJ. 2008. RNA polymerases I and III, non-coding RNAs and cancer. Trends Genet. 24:622–629.
   PubMed Web of Science ®Google Scholar
• White RJ. Transcription by RNA polymerase III: more complex than we thought. Nat. Rev. Genet. 12:459–463.
   PubMedGoogle Scholar
• Pianese G. 1896. Beitrag zur Histologie und Aetiologie der Carcinoma Histologische und experimentelle Untersuchungen. Beitr. Pathol. Anat. Allgem. Pathol. 142:1–193.
   Google Scholar
• Williamson D, Lu YJ, Fang C, Pritchard-Jones K, Shipley J. 2006. Nascent pre-rRNA overexpression correlates with an adverse prognosis in alveolar rhabdomyosarcoma. Genes Chromosomes Cancer 45:839–845.
   PubMed Web of Science ®Google Scholar
• Grummt I. 2003. Life on a planet of its own: regulation of RNA polymerase I transcription in the nucleolus. Genes Dev. 17:1691–1702.
   PubMed Web of Science ®Google Scholar
• Derenzini M, Trere D, Pession A, Govoni M, Sirri V, Chieco P. 2000. Nucleolar size indicates the rapidity of cell proliferation in cancer tissues. J. Pathol. 191:181–186.
   PubMed Web of Science ®Google Scholar
• Derenzini M, Trere D, Pession A, Montanaro L, Sirri V, Ochs RL. 1998. Nucleolar function and size in cancer cells. Am. J. Pathol. 152:1291–1297.
   PubMed Web of Science ®Google Scholar
• Trere D, Ceccarelli C, Montanaro L, Tosti E, Derenzini M. 2004. Nucleolar size and activity are related to pRb and p53 status in human breast cancer. J. Histochem Cytochem. 52:1601–1607.
   PubMed Web of Science ®Google Scholar
• Ayrault O, Andrique L, Fauvin D, Eymin B, Gazzeri S, Seite P. 2006. Human tumor suppressor p14ARF negatively regulates rRNA transcription and inhibits UBF1 transcription factor phosphorylation. Oncogene 25:7577–7586.
   PubMedGoogle Scholar
• Learned RM, Learned TK, Haltiner MM, Tjian RT. 1986. Human rRNA transcription is modulated by the coordinate binding of two factors to an upstream control element. Cell 45:847–857.
   PubMedGoogle Scholar
• Zhai W, Comai L. 2000. Repression of RNA polymerase I transcription by the tumor suppressor p53. Mol. Cell. Biol. 20:5930–5938.
   PubMed Web of Science ®Google Scholar
• Rubbi CP, Milner J. 2003. Disruption of the nucleolus mediates stabilization of p53 in response to DNA damage and other stresses. EMBO J. 22:6068–6077.
   PubMed Web of Science ®Google Scholar
• Sherr CJ. 1998. Tumor surveillance via the ARF-p53 pathway. Genes Dev. 12:2984–2991.
   PubMed Web of Science ®Google Scholar
• Yuan X, Zhou Y, Casanova E, Chai M, Kiss E, Grone HJ, Schutz G, Grummt I. 2005. Genetic inactivation of the transcription factor TIF-IA leads to nucleolar disruption, cell cycle arrest, and p53-mediated apoptosis. Mol. Cell 19:77–87.
   PubMed Web of Science ®Google Scholar
• Chedin S, Laferte A, Hoang T, Lafontaine DL, Riva M, Carles C. 2007. Is ribosome synthesis controlled by pol I transcription? Cell Cycle 6:11–15.
   PubMed Web of Science ®Google Scholar
• Laferte A, Favry E, Sentenac A, Riva M, Carles C, Chedin S. 2006. The transcriptional activity of RNA polymerase I is a key determinant for the level of all ribosome components. Genes Dev. 20:2030–2040.
   PubMed Web of Science ®Google Scholar
• Palmero I, Pantoja C, Serrano M. 1998. p19ARF links the tumour suppressor p53 to Ras. Nature 395:125–126.
   PubMed Web of Science ®Google Scholar
• Fernandez-Medarde A, Santos E. Ras in cancer and developmental diseases. Genes Cancer 2:344–358.
   PubMedGoogle Scholar
• Ayrault O, Andrique L, Larsen CJ, Seite P. 2004. Human Arf tumor suppressor specifically interacts with chromatin containing the promoter of rRNA genes. Oncogene 23:8097–8104.
   PubMed Web of Science ®Google Scholar
• Downward J. 2003. Targeting RAS signalling pathways in cancer therapy. Nat. Rev. Cancer 3:11–22.
   PubMed Web of Science ®Google Scholar
• Grandori C, Gomez-Roman N, Felton-Edkins ZA, Ngouenet C, Galloway DA, Eisenman RN, White RJ. 2005. c-Myc binds to human ribosomal DNA and stimulates transcription of rRNA genes by RNA polymerase I. Nat. Cell Biol. 7:311–318.
   PubMed Web of Science ®Google Scholar
• Grewal SS, Li L, Orian A, Eisenman RN, Edgar BA. 2005. Myc-dependent regulation of rRNA synthesis during Drosophila development. Nat. Cell Biol. 7:295–302.
   PubMedGoogle Scholar
• Shields JM, Pruitt K, McFall A, Shaub A, Der CJ. 2000. Understanding Ras: ‘it ain't over ‘til it's over’. Trends Cell Biol. 10:147–154.
   PubMed Web of Science ®Google Scholar
• Zhang C, Comai L, Johnson DL. 2005. PTEN represses RNA Polymerase I transcription by disrupting the SL1 complex. Mol. Cell. Biol. 25:6899–6911.
   PubMedGoogle Scholar
• Zhang Y, Forys JT, Miceli AP, Gwinn AS, Weber JD. 2011. Identification of DHX33 as a mediator of rRNA synthesis and cell growth. Mol. Cell. Biol. 31:4676–4691.
   PubMed Web of Science ®Google Scholar
• Lessard F, Morin F, Ivanchuk S, Langlois F, Stefanovsky V, Rutka J, Moss T. The ARF tumor suppressor controls ribosome biogenesis by regulating the RNA polymerase I transcription factor TTF-I. Mol. Cell 38:539–550.
   PubMedGoogle Scholar
• Weber JD, Jeffers JR, Rehg JE, Randle DH, Lozano G, Roussel MF, Sherr CJ, Zambetti GP. 2000. p53-independent functions of the p19ARF tumor suppressor. Genes Dev. 14:2358–2365.
   PubMed Web of Science ®Google Scholar
• Itahana K, Bhat KP, Jin A, Itahana Y, Hawke D, Kobayashi R, Zhang Y. 2003. Tumor suppressor ARF degrades B23, a nucleolar protein involved in ribosome biogenesis and cell proliferation. Mol. Cell 12:1151–1164.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Xiong Y, Yarbrough WG. 1998. ARF promotes MDM2 degradation and stabilizes p53: ARF-INK4a locus deletion impairs both the Rb and p53 tumor suppression pathways. Cell 92:725–734.
   PubMed Web of Science ®Google Scholar
• Basu TN, Gutmann DH, Fletcher JA, Glover TW, Collins FS, Downward J. 1992. Aberrant regulation of ras proteins in malignant tumour cells from type 1 neurofibromatosis patients. Nature 356:713–715.
   PubMed Web of Science ®Google Scholar
• Dasgupta B, Yi Y, Chen DY, Weber JD, Gutmann DH. 2005. Proteomic analysis reveals hyperactivation of the mammalian target of rapamycin pathway in neurofibromatosis 1-associated human and mouse brain tumors. Cancer research. 65:2755–2760.
   PubMed Web of Science ®Google Scholar
• Johannessen CM, Reczek EE, James MF, Brems H, Legius E, Cichowski K. 2005. The NF1 tumor suppressor critically regulates TSC2 and mTOR. Proc. Natl. Acad. Sci. U. S. A. 102:8573–8578.
   PubMed Web of Science ®Google Scholar
• Stefanovsky V, Langlois F, Gagnon-Kugler T, Rothblum LI, Moss T. 2006. Growth factor signaling regulates elongation of RNA polymerase I transcription in mammals via UBF phosphorylation and r-chromatin remodeling. Mol. Cell 21:629–639.
   PubMed Web of Science ®Google Scholar
• Stefanovsky VY, Pelletier G, Hannan R, Gagnon-Kugler T, Rothblum LI, Moss T. 2001. An immediate response of ribosomal transcription to growth factor stimulation in mammals is mediated by ERK phosphorylation of UBF. Mol. Cell 8:1063–1073.
   PubMed Web of Science ®Google Scholar
• Zhao J, Yuan X, Frodin M, Grummt I. 2003. ERK-dependent phosphorylation of the transcription initiation factor TIF-IA is required for RNA polymerase I transcription and cell growth. Mol. Cell 11:405–413.
   PubMed Web of Science ®Google Scholar
• Voit R, Grummt I. 2001. Phosphorylation of UBF at serine 388 is required for interaction with RNA polymerase I and activation of rDNA transcription. Proc. Natl. Acad. Sci. U. S. A. 98:13631–13636.
   PubMedGoogle Scholar
• Voit R, Hoffmann M, Grummt I. 1999. Phosphorylation by G1-specific cdk-cyclin complexes activates the nucleolar transcription factor UBF. EMBO J. 18:1891–1899.
   PubMed Web of Science ®Google Scholar
• Hannan KM, Brandenburger Y, Jenkins A, Sharkey K, Cavanaugh A, Rothblum L, Moss T, Poortinga G, McArthur GA, Pearson RB, Hannan RD. 2003. mTOR-dependent regulation of ribosomal gene transcription requires S6K1 and is mediated by phosphorylation of the carboxy-terminal activation domain of the nucleolar transcription factor UBF. Mol. Cell. Biol. 23:8862–8877.
   PubMed Web of Science ®Google Scholar
• Mayer C, Zhao J, Yuan X, Grummt I. 2004. mTOR-dependent activation of the transcription factor TIF-IA links rRNA synthesis to nutrient availability. Genes Dev. 18:423–434.
   PubMed Web of Science ®Google Scholar
• Kawagishi H, Nakamura H, Maruyama M, Mizutani S, Sugimoto K, Takagi M, Sugimoto M. ARF suppresses tumor angiogenesis through translational control of VEGFA mRNA. Cancer Res. 70:4749–4758.
   PubMedGoogle Scholar
• Ghoshal K, Jacob ST. 1997. An alternative molecular mechanism of action of 5-fluorouracil, a potent anticancer drug. Biochem. Pharmacol. 53:1569–1575.
   PubMed Web of Science ®Google Scholar
• Jordan P, Carmo-Fonseca M. 1998. Cisplatin inhibits synthesis of rRNA in vivo. Nucleic Acids Res. 26:2831–2836.
   PubMedGoogle Scholar
• Pondarre C, Strumberg D, Fujimori A, Torres-Leon R, Pommier Y. 1997. In vivo sequencing of camptothecin-induced topoisomerase I cleavage sites in human colon carcinoma cells. Nucleic Acids Res. 25:4111–4116.
   PubMedGoogle Scholar
• Drygin D, Siddiqui-Jain A, O'Brien S, Schwaebe M, Lin A, Bliesath J, Ho CB, Proffitt C, Trent K, Whitten JP, Lim JK, Von Hoff D, Anderes K, Rice WG. 2009. Anticancer activity of CX-3543: a direct inhibitor of rRNA biogenesis. Cancer Res. 69:7653–7661.
   PubMed Web of Science ®Google Scholar
• Drygin D, Lin A, Bliesath J, Ho CB, O'Brien SE, Proffitt C, Omori M, Haddach M, Schwaebe MK, Siddiqui-Jain A, Streiner N, Quin JE, Sanij E, Bywater MJ, Hannan RD, Ryckman D, Anderes K, Rice WG. Targeting RNA polymerase I with an oral small molecule CX-5461 inhibits rRNA synthesis and solid tumor growth. Cancer Res. 71:1418–1430.
   PubMedGoogle Scholar